Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-02-08 Purchase |
2023-02-10 4:27 pm |
C4 Therapeutics Inc. | CCCC | Koppikar Utpal Director |
5,667 | $5.6 | $31,735 | 5,667 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-08-30 Tax Withholding |
2023-08-31 4:10 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
661 | $2.93 | 43,186 (Direct) |
View |
2023-08-30 Exercise |
2023-08-31 4:10 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
2,250 | $0 | 43,186 (Direct) |
View |
2023-08-30 Tax Withholding |
2023-08-31 4:10 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
661 | $2.93 | 120,576 (Direct) |
View |
2023-08-30 Exercise |
2023-08-31 4:10 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
2,250 | $0 | 120,576 (Direct) |
View |
2023-08-30 Tax Withholding |
2023-08-31 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
661 | $2.93 | 43,265 (Direct) |
View |
2023-08-30 Exercise |
2023-08-31 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
2,250 | $0 | 43,265 (Direct) |
View |
2023-07-10 Option Award |
2023-07-12 4:06 pm |
N/A 2033-07-09 |
C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer |
337,300 | $0 | 337,300 (Direct) |
View |
2023-07-03 Option Award |
2023-07-05 4:25 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
3,976 | $2.83 | 306,344 (Direct) |
View |
2023-07-03 Option Award |
2023-07-05 4:24 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
3,887 | $2.83 | 803,167 (Direct) |
View |
2023-07-03 Option Award |
2023-07-05 4:23 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
4,858 | $2.83 | 11,738 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:25 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:24 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | Bessen Laura Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:24 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | DOWNEY BRUCE Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:23 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:23 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:22 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | Koppikar Utpal Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:22 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-04-03 Option Award |
2023-04-04 4:20 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
3,438 | $3.2 | 799,280 (Direct) |
View |
2023-04-03 Option Award |
2023-04-04 4:19 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
3,516 | $3.2 | 302,368 (Direct) |
View |
2023-04-03 Option Award |
2023-04-04 4:19 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
4,298 | $3.2 | 6,880 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 4:46 pm |
N/A 2033-02-12 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
151,000 | $0 | 227,487 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 4:45 pm |
N/A 2033-02-12 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
110,000 | $0 | 115,097 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 4:45 pm |
N/A 2033-02-12 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
110,000 | $0 | 115,176 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 4:45 pm |
N/A 2033-02-12 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
110,000 | $0 | 115,097 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 4:44 pm |
N/A 2033-02-12 |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
151,000 | $0 | 156,097 (Direct) |
View |
2023-02-15 Option Award |
2023-02-15 4:44 pm |
N/A 2033-02-14 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
448,800 | $0 | 475,806 (Direct) |
View |
2023-01-30 Exercise |
2023-02-01 4:11 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
3,750 | $0 | 38,847 (Direct) |
View |
2023-01-30 Tax Withholding |
2023-02-01 4:11 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
1,301 | $7.78 | 38,847 (Direct) |
View |
2023-01-30 Exercise |
2023-02-01 4:10 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
3,750 | $0 | 23,847 (Direct) |
View |
2023-01-30 Tax Withholding |
2023-02-01 4:10 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
1,301 | $7.78 | 23,847 (Direct) |
View |
2023-01-30 Exercise |
2023-02-01 4:10 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
3,750 | $0 | 23,926 (Direct) |
View |
2023-01-30 Tax Withholding |
2023-02-01 4:10 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,222 | $7.78 | 23,926 (Direct) |
View |
2023-01-30 Exercise |
2023-02-01 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
12,500 | $0 | 89,506 (Direct) |
View |
2023-01-30 Tax Withholding |
2023-02-01 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
4,319 | $7.78 | 89,506 (Direct) |
View |
2023-01-30 Exercise |
2023-02-01 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
3,750 | $0 | 23,847 (Direct) |
View |
2023-01-30 Tax Withholding |
2023-02-01 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
1,301 | $7.78 | 23,847 (Direct) |
View |
2023-01-30 Exercise |
2023-02-01 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
3,750 | $0 | 23,847 (Direct) |
View |
2023-01-30 Tax Withholding |
2023-02-01 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
1,301 | $7.78 | 23,847 (Direct) |
View |
2023-01-30 Exercise |
2023-02-01 4:08 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
3,750 | $0 | 95,237 (Direct) |
View |
2023-01-30 Tax Withholding |
2023-02-01 4:08 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
1,301 | $7.78 | 95,237 (Direct) |
View |
2023-01-06 Exercise |
2023-01-06 4:55 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
712 | $0 | 300,809 (Direct) |
View |
2023-01-06 Exercise |
2023-01-06 4:55 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
444 | $4.98 | 300,809 (Direct) |
View |
2023-01-06 Exercise |
2023-01-06 4:55 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
268 | $2.11 | 300,809 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:17 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,568 | $6.38 | 298,140 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:17 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
1,763 | $6.38 | 2,582 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:16 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,725 | $6.38 | 795,842 (Direct) |
View |
2022-10-03 Option Award |
2022-10-04 6:06 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
819 | $8.69 | 819 (Direct) |
View |
2022-10-03 Option Award |
2022-10-04 6:06 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,265 | $8.69 | 794,117 (Direct) |
View |
2022-10-03 Option Award |
2022-10-04 6:05 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,150 | $8.69 | 299,241 (Direct) |
View |
2022-10-03 Exercise |
2022-10-04 6:05 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
712 | $0 | 299,241 (Direct) |
View |
2022-10-03 Exercise |
2022-10-04 6:05 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
445 | $4.98 | 299,241 (Direct) |
View |
2022-10-03 Exercise |
2022-10-04 6:05 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
267 | $2.11 | 299,241 (Direct) |
View |
2022-07-29 Option Award |
2022-08-02 4:24 pm |
N/A 2032-07-28 |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
41,200 | $0 | 41,200 (Direct) |
View |